446 related articles for article (PubMed ID: 7680480)
1. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
Yamamoto T; Nakamura T; Noble NA; Ruoslahti E; Border WA
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1814-8. PubMed ID: 7680480
[TBL] [Abstract][Full Text] [Related]
2. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
Border WA; Noble NA; Yamamoto T; Harper JR; Yamaguchi Yu; Pierschbacher MD; Ruoslahti E
Nature; 1992 Nov; 360(6402):361-4. PubMed ID: 1280332
[TBL] [Abstract][Full Text] [Related]
3. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin.
Schaefer L; Raslik I; Grone HJ; Schonherr E; Macakova K; Ugorcakova J; Budny S; Schaefer RM; Kresse H
FASEB J; 2001 Mar; 15(3):559-61. PubMed ID: 11259366
[TBL] [Abstract][Full Text] [Related]
4. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
Okuda S; Languino LR; Ruoslahti E; Border WA
J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Kim SI; Han DC; Lee HB
J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
[TBL] [Abstract][Full Text] [Related]
7. Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.
Okuda S; Nakamura T; Yamamoto T; Ruoslahti E; Border WA
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9765-9. PubMed ID: 1946401
[TBL] [Abstract][Full Text] [Related]
8. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U
Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
[TBL] [Abstract][Full Text] [Related]
9. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
10. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta isoforms in human glomerular diseases.
Yamamoto T; Noble NA; Cohen AH; Nast CC; Hishida A; Gold LI; Border WA
Kidney Int; 1996 Feb; 49(2):461-9. PubMed ID: 8821830
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in kidney disease: the role of transforming growth factor-beta.
Border WA; Noble NA
Am J Kidney Dis; 1993 Jul; 22(1):105-13. PubMed ID: 8322771
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of extracellular matrix glycoproteins undulin and tenascin in human autosomal dominant polycystic kidney disease.
Klingel R; Ramadori G; Schuppan D; Knittel T; Meyer zum Büschenfelde KH; Köhler H
Nephron; 1993; 65(1):111-8. PubMed ID: 7692313
[TBL] [Abstract][Full Text] [Related]
14. Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.
Wilson PG; Thompson JC; Yoder MH; Charnigo R; Tannock LR
J Lipid Res; 2017 Dec; 58(12):2264-2274. PubMed ID: 28912302
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
McLennan SV; Kelly DJ; Schache M; Waltham M; Dy V; Langham RG; Yue DK; Gilbert RE
Kidney Int; 2007 Aug; 72(4):481-8. PubMed ID: 17554258
[TBL] [Abstract][Full Text] [Related]
16. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S; Hong SW; Iglesias-de la Cruz MC; Isono M; Casaretto A; Ziyadeh FN
Ren Fail; 2001; 23(3-4):471-81. PubMed ID: 11499562
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.
Yang CW; Hattori M; Vlassara H; He CJ; Carome MA; Yamato E; Elliot S; Striker GE; Striker LJ
J Am Soc Nephrol; 1995 Feb; 5(8):1610-7. PubMed ID: 7538809
[TBL] [Abstract][Full Text] [Related]
19. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
Wang SN; Hirschberg R
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
